TrialJournal of neurology2026

Low-dose ticagrelor combined with aspirin for preventing early neurological deterioration in patients with high-risk non-disabling ischemic cerebrovascular events: a multicenter, prospective, randomized, open-label, clinical trial.

Jiahui Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.